Title: Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression Authors: Shuhei Suzuki, Chifumi Kitanaka, Masashi Okada URL: Published: Anticancer Research, September 2024, 44(9):3875-3883 The effects of bremelanotide, a melanocortin receptor agonist, were investigated in human glioblastoma cell lines using in vitro methodologies
In developed countries, men had higher rates of overweight and obesity, while women in developing countries showed higher rates, and in developed countries, the peak of obesity rates is moving at an earlier age presented in the following map ( Figure 1 ) [2]
This broader platform strategy may create additional long-term optionality and commercial flexibility as the obesity treatment market continues evolving
Real Results: Our Clinics Experience At Rheumatologist OnCall, we have implemented a program designed to serve patients with obesity and autoimmune diseases, including arthritis
As you age, your human growth hormone (HGH) levels begin to decline, as do the peptides that stimulate its secretion